Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Diluted Average) (2021 - 2025)

CorMedix (CRMD) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $71.9 million as the latest value for Q2 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 24.94% to $71.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $71.9 million through Jun 2025, up 24.94% year-over-year, with the annual reading at $58.9 million for FY2024, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) hit $71.9 million in Q2 2025 for CorMedix, up from $69.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $71.9 million in Q2 2025 to a low of $37.5 million in Q3 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $48.9 million across 5 years, with a median of $44.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 2.43% in 2022 and later soared 30.42% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $37.7 million in 2021, then increased by 6.92% to $40.3 million in 2022, then grew by 20.96% to $48.7 million in 2023, then rose by 20.85% to $58.9 million in 2024, then grew by 22.16% to $71.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CRMD at $71.9 million in Q2 2025, $69.0 million in Q1 2025, and $58.9 million in Q4 2024.